{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:04:31Z","timestamp":1788869071224,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Homozygous or compound heterozygous variants in\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      , which transcribes a non-coding RNA component of the minor spliceosome, have been associated with a spectrum of disorders, collectively known as\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      -related spliceosomeopathies. The phenotypic spectrum of\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      -related disease is characterized by dysmorphic features, growth delay, neurological and skeletal features, whose severity ranges from the microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1) to the milder Roifman syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To characterize the clinical spectrum and evaluate long-term outcomes of\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      -related diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We evaluated the phenotypic features of four novel patients with deleterious\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      variants, diagnosed by means of whole genome sequencing. Same features were evaluated in previously published cases, identified by literature research on PubMed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified four novel cases with deleterious compound heterozygous variants in\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      , which were not restricted to the 5\u2019 stem-loop, including three adult patients. Reported cases expand the clinical spectrum of\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      -related disorders, highlighting renal disease, autoimmunity and systemic inflammation as possibly more frequent yet previously under-recognized features. Immunological investigations reveal enhanced HLA-DR and PD-1 expression in T cells from tested patients, suggesting T cell activation and exhaustion. Reevaluation of all previously published cases confirms the strong correlation of\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      variants located exclusively at the 5\u2019 stem-loop with severe lethal disease falling under MOPD1. Genotypes carrying at least one variant that spares the 5\u2032 stem-loop are associated with a milder phenotype and later onset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Homozygous or compound heterozygous\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      variants affecting the 5\u2019 stem-loop region are associated with severe phenotypes and adverse disease courses. In contrast, genotypes sparing the critical 5\u2032 stem-loop region of\n                      <jats:italic>RNU4ATAC<\/jats:italic>\n                      can cause a complex phenotype that is not necessarily dominated by dysmorphic features or growth failure, but rather by immunodeficiency and immune dysregulation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04300-x","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:36:23Z","timestamp":1773135383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic spectrum of RNU4ATAC-related spliceosomopathies: four novel cases and integrated reevaluation of previously reported patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Svjetlana","family":"Lovric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrine","family":"Berking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C.","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"K\u00f6rholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Porrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"H\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Br\u00e4sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai M.","family":"Schmidt-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"von Hardenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-2945","authenticated-orcid":false,"given":"Georgios","family":"Sogkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4300_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/wrna.1141","volume":"4","author":"JJ Turunen","year":"2013","unstructured":"Turunen JJ, Niemel\u00e4 EH, Verma B, Frilander MJ. The significant other: splicing by the minor spliceosome. Wiley Interdiscip Rev RNA. 2013;4:61\u201376.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"4300_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tig.2012.01.001","volume":"28","author":"RA Padgett","year":"2012","unstructured":"Padgett RA. New connections between splicing and human disease. Trends Genet. 2012;28:147\u201354.","journal-title":"Trends Genet"},{"key":"4300_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1261\/rna.080337.124","volume":"31","author":"AJ Norppa","year":"2025","unstructured":"Norppa AJ, Shcherbii MV, Frilander MJ. Connecting genotype and phenotype in minor spliceosome diseases. RNA. 2025;31:284\u201399.","journal-title":"RNA"},{"key":"4300_CR4","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1093\/nar\/gkf609","volume":"30","author":"GC Shukla","year":"2002","unstructured":"Shukla GC, Cole AJ, Dietrich RC, Padgett RA. Domains of human U4atac snRNA required for U12-dependent splicing in vivo. Nucleic Acids Res. 2002;30:4650\u20137.","journal-title":"Nucleic Acids Res"},{"key":"4300_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S1355838202017156","volume":"8","author":"RA Padgett","year":"2002","unstructured":"Padgett RA, Shukla GC. A revised model for U4atac\/U6atac snRNA base pairing. RNA. 2002;8:125\u20138.","journal-title":"RNA"},{"key":"4300_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1261\/rna.2690611","volume":"17","author":"S Liu","year":"2011","unstructured":"Liu S, Ghalei H, L\u00fchrmann R, Wahl MC. Structural basis for the dual U4 and U4atac snRNA-binding specificity of spliceosomal protein hPrp31. RNA. 2011;17:1655\u201363.","journal-title":"RNA"},{"key":"4300_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1200587","volume":"332","author":"H He","year":"2011","unstructured":"He H, Liyanarachchi S, Akagi K, Nagy R, Li J, Dietrich RC, et al. Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science. 2011;332:238\u201340.","journal-title":"Science"},{"key":"4300_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1126\/science.1202205","volume":"332","author":"P Edery","year":"2011","unstructured":"Edery P, Marcaillou C, Sahbatou M, Labalme A, Chastang J, Touraine R, et al. Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA. Science. 2011;332:240\u20133.","journal-title":"Science"},{"key":"4300_CR9","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1038\/ncomms9718","volume":"6","author":"D Merico","year":"2015","unstructured":"Merico D, Roifman M, Braunschweig U, Yuen RK, Alexandrova R, Bates A, et al. Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing. Nat Commun. 2015;6:8718.","journal-title":"Nat Commun"},{"key":"4300_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ajmg.a.38581","volume":"176","author":"LS Farach","year":"2018","unstructured":"Farach LS, Little ME, Duker AL, Logan CV, Jackson A, Hecht JT, Bober M. The expanding phenotype of RNU4ATAC pathogenic variants to Lowry Wood syndrome. Am J Med Genet A. 2018;176:465\u20139.","journal-title":"Am J Med Genet A"},{"key":"4300_CR11","unstructured":"Duker A, Velasco D, Robertson N, Jackson A, DeFelice M, Bober MB. RNU4atac-opathy. GeneReviews\u00ae [Internet]. 2023."},{"key":"4300_CR12","doi-asserted-by":"publisher","first-page":"e0235655","DOI":"10.1371\/journal.pone.0235655","volume":"15","author":"C Benoit-Pilven","year":"2020","unstructured":"Benoit-Pilven C, Besson A, Putoux A, Benetollo C, Saccaro C, Guguin J, et al. Clinical interpretation of variants identified in RNU4ATAC, a non-coding spliceosomal gene. PLoS ONE. 2020;15:e0235655.","journal-title":"PLoS ONE"},{"key":"4300_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaci.2017.11.061","volume":"142","author":"J Heremans","year":"2018","unstructured":"Heremans J, Garcia-Perez JE, Turro E, Schlenner SM, Casteels I, Collin R, et al. Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome. J Allergy Clin Immunol. 2018;142:630\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"4300_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1261\/rna.071423.119","volume":"25","author":"A Cologne","year":"2019","unstructured":"Cologne A, Benoit-Pilven C, Besson A, Putoux A, Campan-Fournier A, Bober MB, et al. New insights into minor splicing-a transcriptomic analysis of cells derived from TALS patients. RNA. 2019;25:1130\u201349.","journal-title":"RNA"},{"key":"4300_CR15","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1093\/nar\/gkab118","volume":"49","author":"AM Olthof","year":"2021","unstructured":"Olthof AM, White AK, Mieruszynski S, Doggett K, Lee MF, Chakroun A, et al. Disruption of exon-bridging interactions between the minor and major spliceosomes results in alternative splicing around minor introns. Nucleic Acids Res. 2021;49:3524\u201345.","journal-title":"Nucleic Acids Res"},{"key":"4300_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/ajmg.a.63110","volume":"191","author":"A Tabib","year":"2023","unstructured":"Tabib A, Richmond CM, McGaughran J. Delineating the phenotype of RNU4ATAC-related spliceosomopathy. Am J Med Genet A. 2023;191:1094\u2013100.","journal-title":"Am J Med Genet A"},{"key":"4300_CR17","doi-asserted-by":"publisher","first-page":"e2102569120","DOI":"10.1073\/pnas.2102569120","volume":"120","author":"D Khatri","year":"2023","unstructured":"Khatri D, Putoux A, Cologne A, Kaltenbach S, Besson A, Bertiaux E, et al. Deficiency of the minor spliceosome component U4atac snRNA secondarily results in ciliary defects in human and zebrafish. Proc Natl Acad Sci U S A. 2023;120:e2102569120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4300_CR18","doi-asserted-by":"publisher","first-page":"1552513","DOI":"10.3389\/fimmu.2025.1552513","volume":"16","author":"D Dogru","year":"2025","unstructured":"Dogru D, Dogru Y, Atschekzei F, Elsayed A, Dubrowinskaja N, Ernst D, et al. Reappraisal of IgG subclass deficiencies: a retrospective comparative cohort study. Front Immunol. 2025;16:1552513. https:\/\/doi.org\/10.3389\/fimmu.2025.1552513.","journal-title":"Front Immunol"},{"key":"4300_CR19","doi-asserted-by":"publisher","first-page":"110504","DOI":"10.1016\/j.clim.2025.110504","volume":"276","author":"A Elsayed","year":"2025","unstructured":"Elsayed A, von Hardenberg S, Atschekzei F, Siek P, Witte T, Sogkas G, Ringshausen FC. A novel hemizygous nonsense variant in DOCK11 causes systemic inflammation and immunodeficiency. Clin Immunol. 2025;276:110504. https:\/\/doi.org\/10.1016\/j.clim.2025.110504.","journal-title":"Clin Immunol"},{"key":"4300_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"4300_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"4300_CR22","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.ekir.2025.04.017","volume":"10","author":"EAE Elhassan","year":"2025","unstructured":"Elhassan EAE, Cormican S, Osman SM, Sarihan S, Teltsh O, Poynton FE, Griffin MD, Casserly L, McCann E, Bleyer AJ, Sr, Kmoch S, \u017divn\u00e1 M, Benson KA, Cavalleri GL, Conlon PJ. Characterization of Monogenic Kidney Disease in Older Patients With CKD. Kidney Int Rep. 2025;10:2140\u201352.","journal-title":"Kidney Int Rep"},{"key":"4300_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/bjh.16260","volume":"188","author":"L Elston","year":"2020","unstructured":"Elston L, Fegan C, Hills R, Hashimdeen SS, Walsby E, Henley P, et al. Increased frequency of CD4\u2009+\u2009PD-1\u2009+\u2009HLA-DR\u2009+\u2009T cells is associated with disease progression in CLL. Br J Haematol. 2020;188:872\u201380.","journal-title":"Br J Haematol"},{"key":"4300_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/cge.14571","volume":"106","author":"LW Gauthier","year":"2024","unstructured":"Gauthier LW, Gossez M, Malcus C, Viel S, Monneret G, Bordonn\u00e9 R, et al. B-cell immune deficiency in twin sisters expands the phenotype of MOPDI. Clin Genet. 2024;106:476\u201382.","journal-title":"Clin Genet"},{"key":"4300_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126:458\u201365.","journal-title":"Immunology"},{"key":"4300_CR26","doi-asserted-by":"publisher","first-page":"e202451518","DOI":"10.1002\/eji.202451518","volume":"55","author":"N Robertson","year":"2025","unstructured":"Robertson N, Joshi A, Ritchie F, van der Schim I, Royan D, Duker AL, et al. Mutations in RNU4ATAC Are Associated With Chilblain-Like Lesions and Enhanced Type I Interferon Signalling. Eur J Immunol. 2025;55:e202451518.","journal-title":"Eur J Immunol"},{"key":"4300_CR27","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/ccr3.1830","volume":"6","author":"A Hallermayr","year":"2018","unstructured":"Hallermayr A, Graf J, Koehler U, Laner A, Sch\u00f6nfeld B, Benet-Pag\u00e8s A, Holinski-Feder E. Extending the critical regions for mutations in the non-coding gene RNU4ATAC in another patient with Roifman Syndrome. Clin Case Rep. 2018;6:2224\u20138.","journal-title":"Clin Case Rep"},{"key":"4300_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41525-017-0024-5","volume":"2","author":"Y Dinur Schejter","year":"2017","unstructured":"Dinur Schejter Y, Ovadia A, Alexandrova R, Thiruvahindrapuram B, Pereira SL, Manson DE, et al. A homozygous mutation in the stem II domain of RNU4ATAC causes typical Roifman syndrome. NPJ Genom Med. 2017;2:23.","journal-title":"NPJ Genom Med"},{"key":"4300_CR29","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1002\/ehf2.14518","volume":"10","author":"Q Xi","year":"2023","unstructured":"Xi Q, Plaza Enriquez LJ, Tanni NU, Patsias I. Underdiagnosed Roifman syndrome manifested as non-ischaemic cardiomyopathy: a case report. ESC Heart Fail. 2023;10:3195\u20138.","journal-title":"ESC Heart Fail"},{"key":"4300_CR30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/nar\/gkac1182","volume":"51","author":"F Almentina Ramos Shidi","year":"2023","unstructured":"Almentina Ramos Shidi F, Cologne A, Delous M, Besson A, Putoux A, et al. Mutations in the non-coding RNU4ATAC gene affect the homeostasis and function of the Integrator complex. Nucleic Acids Res. 2023;51:712\u201327.","journal-title":"Nucleic Acids Res"},{"key":"4300_CR31","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1038\/s41433-023-02581-1","volume":"37","author":"BG Ballios","year":"2023","unstructured":"Ballios BG, Mandola A, Tayyib A, Tumber A, Garkaby J, Vong L, et al. Deep phenotypic characterization of the retinal dystrophy in patients with RNU4ATAC-associated Roifman syndrome. Eye (Lond). 2023;37:3734\u201342.","journal-title":"Eye (Lond)"},{"key":"4300_CR32","doi-asserted-by":"publisher","first-page":"e249109","DOI":"10.1136\/bcr-2022-249109","volume":"15","author":"D Clifford","year":"2022","unstructured":"Clifford D, Moloney F, Leahy TR, Murray DM. Roifman syndrome: a description of further immunological and radiological features. BMJ Case Rep. 2022;15:e249109.","journal-title":"BMJ Case Rep"},{"key":"4300_CR33","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1002\/ajmg.a.62457","volume":"185","author":"HJ McMillan","year":"2021","unstructured":"McMillan HJ, Davila J, Osmond M, Chakraborty P, Care4Rare Canada Consortium, Boycott KM, et al. Whole genome sequencing identifies pathogenic RNU4ATAC variants in a child with recurrent encephalitis, microcephaly, and normal stature. Am J Med Genet A. 2021;185:3502\u20136.","journal-title":"Am J Med Genet A"},{"key":"4300_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00439-018-1950-8","volume":"137","author":"I Shelihan","year":"2018","unstructured":"Shelihan I, Ehresmann S, Magnani C, Forzano F, Baldo C, Brunetti-Pierri N, Campeau PM. Lowry-Wood syndrome: further evidence of association with RNU4ATAC, and correlation between genotype and phenotype. Hum Genet. 2018;137:905\u20139.","journal-title":"Hum Genet"},{"key":"4300_CR35","first-page":"159","volume":"3","author":"Y Dinur Schejter","year":"2016","unstructured":"Dinur Schejter Y, Merico D, Manson D, Reid B, Vong L. A novel mutation in Roifman syndrome redefines the boundaries of the Sm protein-binding site. LymphoSign J. 2016;3:159\u201363.","journal-title":"LymphoSign J"},{"key":"4300_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.braindev.2020.09.007","volume":"43","author":"H Hagiwara","year":"2021","unstructured":"Hagiwara H, Matsumoto H, Uematsu K, Zaha K, Sekinaka Y, Miyake N, et al. Immunodeficiency in a patient with microcephalic osteodysplastic primordial dwarfism type I as compared to Roifman syndrome. Brain Dev. 2021;43:337\u201342.","journal-title":"Brain Dev"},{"key":"4300_CR37","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1038\/s41598-017-02434-4","volume":"7","author":"DJ Bogaert","year":"2017","unstructured":"Bogaert DJ, Dullaers M, Kuehn HS, Leroy BP, Niemela JE, De Wilde H, et al. Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman-Steiner and Roifman syndromes. Sci Rep. 2017;7:3702.","journal-title":"Sci Rep"},{"key":"4300_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MCD.0000000000000110","volume":"25","author":"AB Kr\u00f8ig\u00e5rd","year":"2016","unstructured":"Kr\u00f8ig\u00e5rd AB, Jackson AP, Bicknell LS, Baple E, Brusgaard K, Hansen LK, Ousager LB. Two novel mutations in RNU4ATAC in two siblings with an atypical mild phenotype of microcephalic osteodysplastic primordial dwarfism type 1. Clin Dysmorphol. 2016;25:68\u201372.","journal-title":"Clin Dysmorphol"},{"key":"4300_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bone.2016.08.023","volume":"92","author":"AB Kr\u00f8ig\u00e5rd","year":"2016","unstructured":"Kr\u00f8ig\u00e5rd AB, Frost M, Larsen MJ, Ousager LB, Frederiksen AL. Bone structure in two adult subjects with impaired minor spliceosome function resulting from RNU4ATAC mutations causing microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1). Bone. 2016;92:145\u20139.","journal-title":"Bone"},{"key":"4300_CR40","doi-asserted-by":"publisher","first-page":"bcr2016215502","DOI":"10.1136\/bcr-2016-215502","volume":"2016","author":"S Ferrell","year":"2016","unstructured":"Ferrell S, Johnson A, Pearson W. Microcephalic osteodysplastic primordial dwarfism type 1. BMJ Case Rep. 2016;2016:bcr2016215502. https:\/\/doi.org\/10.1136\/bcr-2016-215502.","journal-title":"BMJ Case Rep"},{"key":"4300_CR41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/cge.12781","volume":"90","author":"A Putoux","year":"2016","unstructured":"Putoux A, Alqahtani A, Pinson L, Paulussen AD, Michel J, Besson A, et al. Refining the phenotypical and mutational spectrum of Taybi-Linder syndrome. Clin Genet. 2016;90:550\u20135.","journal-title":"Clin Genet"},{"key":"4300_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ajmg.a.37409","volume":"170A","author":"GM Abdel-Salam","year":"2016","unstructured":"Abdel-Salam GM, Emam BA, Khalil YM, Abdel-Hamid MS. Long-term survival in microcephalic osteodysplastic primordial dwarfism type I: Evaluation of an 18-year-old male with g.55G\u2009>\u2009A homozygous mutation in RNU4ATAC. Am J Med Genet A. 2016;170A:277\u201382.","journal-title":"Am J Med Genet A"},{"key":"4300_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ajmg.a.36955","volume":"167A","author":"E Kilic","year":"2015","unstructured":"Kilic E, Yigit G, Utine GE, Wollnik B, Mihci E, Nur BG, Boduroglu K. A novel mutation in RNU4ATAC in a patient with microcephalic osteodysplastic primordial dwarfism type I. Am J Med Genet A. 2015;167A:919\u201321.","journal-title":"Am J Med Genet A"},{"key":"4300_CR44","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/ajmg.a.36009","volume":"161A","author":"GM Abdel-Salam","year":"2013","unstructured":"Abdel-Salam GM, Abdel-Hamid MS, Hassan NA, Issa MY, Effat L, Ismail S, et al. Further delineation of the clinical spectrum in RNU4ATAC related microcephalic osteodysplastic primordial dwarfism type I. Am J Med Genet A. 2013;161A:1875\u201381.","journal-title":"Am J Med Genet A"},{"key":"4300_CR45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1399-0004.2011.01756.x","volume":"82","author":"R Nagy","year":"2012","unstructured":"Nagy R, Wang H, Albrecht B, Wieczorek D, Gillessen-Kaesbach G, Haan E, et al. Microcephalic osteodysplastic primordial dwarfism type I with biallelic mutations in the RNU4ATAC gene. Clin Genet. 2012;82:140\u20136.","journal-title":"Clin Genet"},{"key":"4300_CR46","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/ajmg.a.34299","volume":"155A","author":"GM Abdel-Salam","year":"2011","unstructured":"Abdel-Salam GM, Miyake N, Eid MM, Abdel-Hamid MS, Hassan NA, Eid OM, et al. A homozygous mutation in RNU4ATAC as a cause of microcephalic osteodysplastic primordial dwarfism type I (MOPD I) with associated pigmentary disorder. Am J Med Genet A. 2011;155A:2885\u201396.","journal-title":"Am J Med Genet A"},{"key":"4300_CR47","doi-asserted-by":"publisher","first-page":"e20250003","DOI":"10.70962\/jhi.20250003","volume":"1","author":"MC Poli","year":"2025","unstructured":"Poli MC, Aksentijevich I, Bousfiha AA, Cunningham-Rundles C, Hambleton S, Klein C, et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. J Hum Immun. 2025;1:e20250003. https:\/\/doi.org\/10.70962\/jhi.20250003.","journal-title":"J Hum Immun"},{"key":"4300_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/jmg.32.3.234","volume":"32","author":"J Eason","year":"1995","unstructured":"Eason J, Hall CM, Trounce JQ. Renal tubular leakage complicating microcephalic osteodysplastic primordial dwarfism. J Med Genet. 1995;32:234\u20135.","journal-title":"J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04300-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:44:37Z","timestamp":1781639077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04300-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04300-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent for genetic analyses was obtained within the framework of clinical care and included approval for research use. Ethical approval was obtained\/exempted according to the requirements of the local institutional review board (approval 11223_BO_K_2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical data was obtained from the patients\/legal guardians. Additional consent was obtained for the publication of patient facial images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}